15:57 , Jun 7, 2017 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Cancer In vitro and mouse studies suggest a cell-penetrating antibody targeting activated KRAS could help treat KRAS-mutant cancers. In a panel of KRAS-mutant human cancer cell lines, a cell-penetrating IgG1 antibody against KRAS, modified...
13:23 , May 31, 2017 |  BC Innovations  |  Distillery Therapeutics

Pulmonary

INDICATION: Pulmonary Patient sample and mouse studies suggest inhibiting KRAS or MCP-1 could help treat malignant pleural effusions in KRAS-mutant cancers. In non-small cell lung cancer (NSCLC) patients, KRAS mutations in metastatic tumors were associated...